|
Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene
RECRUITINGSponsored by Institut Bergonié
Actively Recruiting
SponsorInstitut Bergonié
Started2023-06-12
Est. completion2048-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05630105
Summary
This is a multicentric, observational, retrospective and prospective study, aiming to estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the constitution of a national cohort.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: 1. Male or female. 2. Adult or child without age limit. 3. Carrier of a constitutional or mosaic alteration of the PTEN gene established and/or confirmed by the Institut Bergonié's genetics laboratory, following a request for molecular diagnosis made between 1997 and 2027. 4. Participant informed of his genetic diagnosis. 5. Participant informed and not having expressed non-opposition to participate in the research. 6. Participant affiliated to a French social security system in accordance with French law on research involving the human person. Exclusion Criteria: 1. Participant under guardianship or curatorship. Exception: a participant with autism may be included in the study. 2. Persons deprived of their liberty by a judicial or administrative decision. 3. Persons under psychiatric care, persons admitted to a health or social establishment for purposes other than research; Exception: a participant with autism may be included in the study.
Conditions2
CancerPTEN Gene Mutation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorInstitut Bergonié
Started2023-06-12
Est. completion2048-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05630105